Oral Contraceptives and Body Mass Index
Completed · Phase 4
Conditions studied: Body Weight, Contraceptive Usage
In brief
The main hypothesis for this study is that increased Body Mass Index (BMI) alters oral contraceptive metabolism in a manner which results in decreased effectiveness in obese women.
Key facts
- Study ID
- NCT01170390
- Run by
- Oregon Health and Science University
- People needed
- 32
- Starts
- 2009-09-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2015-12-31
Who can join
Age: 18 and older, up to 35. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Age 18-35
- BMI > 30kg/m2
- Proof of a normal breast and pelvic exam within last 9 months
- Self reported normal menstrual periods (24-35 days)
- Good general health
- In the investigator's opinion, are subject's veins suitable the repeat blood draws dictated by study protocol
- Single progesterone level during screening visit ≥ 3ng/mL
- Hematocrit ≥ 36%
You may not qualify if…
- Contradictions to COCs (history of deep vein thrombosis,myocardial infection, uncontrolled hypertension, pulmonary embolus, diabetes with vascular changes, stroke, migraines with neurologic changes, breast cancer, impaired liver function, uncontrolled thyroid disease, hypersensitivity or allergy to birth control)
- Smoker (must smoke 0 cigarettes)
- Actively seeking/involved in a weight loss program
- Currently pregnant/seeking pregnancy in the next 6 months
- Currently breast-feeding
- Past or current diagnosis of polycystic ovarian disease
- Recent use of birth control (Depot medroxyprogesterone: 6 months, Progestin implants: 6 months, Oral contraceptives, patch or ring: 2 months, Hormone impregnated IUD: 6 months)
- Currently taking medication that interferes with COC's (Rifampin, Carbamazepine, St. John's Wort)
Where it is running
- Oregon Health and Science University — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.